The Food and Drug Administration will delay its decision on authorizing Moderna Inc’s vaccine for adolescents while it examines whether it leads to an inflammatory heart condition, the Wall St. Journal has reported. The move comes after four Nordic countries have taken stronger stances against giving Moderna vaccines to … Read entire story.
Source: Deadline